ABSTRACT
La Yersinia enterocolitica o la Yersinia pseudotuberculosis pueden tener diferentes formas de presentación entre las que están la enteritis o enterocolitis, la adenitis mesentérica asociada a ileitis distal, la septicemia, infecciones localizadas o manifestaciones extraintestinales. Es responsable de hasta 7 por ciento de los cuadros de gastroenteritis infecciosas y se asocia a una elevada mortalidad post-infección a corto y largo plazo, de 2 a 3 veces mayor. Esta infección bacteriana se adquiere mediante la ingesta oral de productos contaminados y/o inadecuadamente preparados. El aislamiento de Yersinia en las deposiciones es el examen más específico y siempre debe ser solicitado. Debido a su baja sensibilidad los estudios serológicos pueden ser útiles para el diagnóstico, y la reacción de polimerasa en cadena (PCR) puede constituirse próximamente en el examen de elección para el diagnóstico de esta infección. Los antibióticos útiles para su tratamiento son los aminoglicósidos, cefalosporinas de tercera generación, cloranfenicol, quinolonas, tetraciclinas y trimetoprim-sulfametoxazol.
Yersinia enterocolitica or yersinia pseudotuberculosis may have different presentation forms: among those are enteritis or enterocholitis, mesenteric adenitis associated with distal ileitis, septicemia, localized infections or extra-intestinal manifestations. It is responsible for up to 7 percent of infectious gastroenteritis and is associated with high post-infection mortality in the short and long term, which is 2 to 3 times higher. This bacterial infection is acquired through oral consumption of contaminated and/or inappropriately prepared products. Isolation of Yersinia in stool samples is the more specific exam and it should always be performed. Due to its low sensibility, serological studies may be useful for the diagnosis, and the polymerase chain reaction (PCR) may become the elective exam for the diagnosis of this infection in the future. Antibiotics that are useful for its treatment are aminoglycoside, third-generation cephalosporins, chloramphenicol, quinolones, tetracyclines, and Trimetoprim-sulfametoxasol.
Subject(s)
Humans , Gastroenteritis/microbiology , Yersinia Infections/diagnosis , Yersinia Infections/physiopathology , Yersinia Infections/drug therapy , Anti-Bacterial Agents/therapeutic use , Feces/microbiology , Serologic Tests , Polymerase Chain Reaction , Yersinia enterocolitica/isolation & purification , Yersinia enterocolitica/pathogenicity , Yersinia pseudotuberculosis/isolation & purification , Yersinia pseudotuberculosis/pathogenicityABSTRACT
Ribotyping and virulence markers has been used to investigate 68 Yersinia pseudotuberculosis strains of serogroups O:1a and O:3. The strains were isolated from clinical material obtained from healthy and sick animals in the Southern region of Brazil. Ribotypes were identified by double digestion of extracted DNA with the restriction endonucleases SmaI and PstI, separation by electrophoresis and hybridization with a digoxigenin-labeled cDNA probe. The presence of the chromosomal virulence marker genes inv, irp1, irp2, psn, ybtE, ybtP-ybtQ, and ybtX-ybtS, of the IS100 insertion sequence, and of the plasmid gene lcrF was detected by polymerase chain reaction. The strains were grouped into four distinct ribotypes, all of them comprising several strains. Ribotypes 1 and 4 presented distinct profiles, with 57.3 percent genetic similarity, ribotypes 2 and 3 presented 52.5 percent genetic similarity, and genetic similarity was 45 percent between these two groups (1/4 and 2/3). All strains possessed the inv, irp1, and irp2 genes. Additionally, strains of serogroup O:1a carried psn, ybtE, ybtP-ybtQ, ybtX-ybtS, and IS100. As expected lcrF was only detected in strains harboring the virulence plasmid. These data demonstrate the presence of Y. pseudotuberculosis strains harboring genotypic virulence markers in the livestock from Southern Brazil and that the dissemination of these bacteria may occur between herds.